Circadian timing of olaparib dosing and progression-free survival in platinum-sensitive ovarian cancer: a real-world single-center study

International Journal of Gynecological Cancer 2026

View at publisher

Authors: Ivan Bivolarski

DOI: 10.1016/j.ijgc.2025.103865

Cited by: 0

Fields of Study & Subjects

PARP inhibition in cancer therapy Ovarian cancer diagnosis and treatment BRCA gene mutations in cancer